NIH COVID-19 Treatment Guidelines Panel, 2022-04-29: The US NIH treatment guideline's ivermectin section, last updated 29 April 2022, recommending against ivermectin for COVID-19 outside clinical trials (strength AIIa).
The Panel recommends against the use of ivermectin for the treatment of COVID-19, except in clinical trials
NIH COVID-19 Treatment Guidelines Panel, 2022-04-29: The US NIH treatment guideline's ivermectin section, last updated 29 April 2022, recommending against ivermectin for COVID-19 outside clinical trials (strength AIIa). Study type: regulatory record.
